The global Mutation Detection Kits In Genome Editing market size is expected to be worth around US$ 565.1 million by 2030, according to a new report by Vision Research Reports.
The global Mutation Detection Kits In Genome Editing market size was valued at US$ 226.9 million in 2020 and is anticipated to grow at a CAGR of 18.3% during forecast period 2021 to 2030.
Report Coverage
Report Scope | Details |
Market Size | US$ 565.1 million by 2030 |
Growth Rate | CAGR of 18.3% From 2021 to 2030 |
Largest Market | North America |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Technology by application, End-use |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | Thermo Fisher Scientific; Takara Bio Inc.; Integrated DNA Technologies, Inc.; Lucigen; Promega Corporation; GenScript; Synthego; New England Biolabs; Applied Biological Materials, Inc. (abm); Bio-Rad Laboratories; AddGene; Biovision Inc. |
Growth Factors
Widespread usage of genome editing techniques, coupled with the increasing investment flow in the development of mutation detection kits to accelerate the adoption of genome editing methodologies, has majorly driven the growth of the market. The discovery of polymorphisms and unknown mutations in genome sequences is a significant aspect of widespread research and clinical areas, including pharmacogenetics, disease treatment, and reverse genetics study in model organisms. This has driven the adoption of mutation detection kits in genome manipulation space, in turn, propelling the market growth throughout the forecast period.
By Technology By Application Analysis
CRISPR/Cas9 technology dominated the market in 2020 with a share of over 40.0%. The emergence of this technology has revolutionized the field of medical diagnostics and research on genetic testing.
The researchers combined CRISPR with graphene electronic transistors in this new device to detect specific gene mutations in a very small timeframe. This device, named CRISPR-Chip, can diagnose genetic diseases in less time and can also be used for the evaluation of the accuracy of genome-editing technologies.
Limitations associated with the CRISPR technique have resulted in increased applications of TALEN technology in some genomic regions that are hard to edit. A study was published in January 2021, which stated that for compact DNA studies, TALEN was found to be a more suitable tool.
By End-use Analysis
Academic and government research institutes dominated the market with a revenue share of over 50.0% in 2020 owing to the ongoing clinical trials, a rise in the preference of personalized medicine, and R&D activities in clinical diagnostics. Moreover, the outbreak of COVID-19 has served as a catalyst for market expansion.
Several research institutes across the globe are actively involved in conducting studies to evaluate the use of various genome editing technologies in mutation detection.
The increasing involvement of biotechnology and pharmaceutical companies is also anticipated to significantly contribute to market growth.
By Regional Analysis
North America dominated the market and accounted for a revenue share of over 35.0% in 2020. This growth in the region can be attributed to the presence of a substantial number of market players, high R&D investments, and continuous technological developments by key players.
Asia Pacific is likely to witness the fastest growth over the forecast period. China was the first country that has successfully transferred genetically modified cells into human cells, to treat lung cancer and boost immunity.
Key Players
Thermo Fisher Scientific
Takara Bio Inc.
Integrated DNA Technologies, Inc.
Lucigen
Promega Corporation
GenScript
Synthego
New England Biolabs
Applied Biological Materials, Inc. (abm)
Bio-Rad Laboratories
AddGene
Biovision Inc.
Market Segmentation
Technology by Application
CRISPR/Cas9
Genetically Modified Organisms (GMO) Analysis
Disease Genotyping
Typing of Transgenic Plants
Therapy Development
Epigenetic Editing
ZFN
Genetically Modified Organisms (GMO) Analysis
Disease Genotyping
Typing of Transgenic Plants
Therapy Development
Epigenetic Editing
TALENs/MegaTALs
Genetically Modified Organisms (GMO) Analysis
Disease Genotyping
Typing Of Transgenic Plants
Therapy Development
Epigenetic Editing
Meganucleases
Genetically Modified Organisms (GMO) Analysis
Disease Genotyping
Typing of Transgenic Plants
Therapy Development
Epigenetic Editing
Others
By End-use
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Contract Research Organizations
Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Asia Pacific
Japan
China
India
South Korea
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Saudi Arabia
The Mutation Detection Kits In Genome Editing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Mutation Detection Kits In Genome Editing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Mutation Detection Kits In Genome Editing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mutation Detection Kits In Genome Editing market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Mutation Detection Kits In Genome Editing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Mutation Detection Kits In Genome Editing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Mutation Detection Kits In Genome Editing by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Mutation Detection Kits In Genome Editing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Mutation Detection Kits In Genome Editing market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Mutation Detection Kits In Genome Editing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Mutation Detection Kits In Genome Editing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Mutation Detection Kits In Genome Editing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Mutation Detection Kits In Genome Editing market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Mutation Detection Kits In Genome Editing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Mutation Detection Kits In Genome Editing market. These factors have benefited the growth of the global market for Mutation Detection Kits In Genome Editing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Mutation Detection Kits In Genome Editing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Mutation Detection Kits In Genome Editing are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Mutation Detection Kits In Genome Editing Market, By Technology by Application
7.1. Mutation Detection Kits In Genome Editing Market, by Technology by Application, 2021-2030
7.1.1. CRISPR/Cas9
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. ZFN
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. TALENs/MegaTALs
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Meganucleases
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Mutation Detection Kits In Genome Editing Market, By End-use
8.1. Mutation Detection Kits In Genome Editing Market, by End-use, 2021-2030
8.1.1. Biotechnology and Pharmaceutical Companies
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Academic and Government Research Institutes
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Contract Research Organizations
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Mutation Detection Kits In Genome Editing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.1.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.2.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Technology by Application (2017-2030)
9.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 10. Company Profiles
10.1. Thermo Fisher Scientific
10.1.1. Company Overview
10.1.2. Technology by Application Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Takara Bio Inc.
10.2.1. Company Overview
10.2.2. Technology by Application Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Integrated DNA Technologies, Inc.
10.3.1. Company Overview
10.3.2. Technology by Application Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Lucigen
10.4.1. Company Overview
10.4.2. Technology by Application Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Promega Corporation
10.5.1. Company Overview
10.5.2. Technology by Application Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. GenScript
10.6.1. Company Overview
10.6.2. Technology by Application Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Synthego
10.7.1. Company Overview
10.7.2. Technology by Application Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. New England Biolabs
10.8.1. Company Overview
10.8.2. Technology by Application Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Applied Biological Materials, Inc. (abm)
10.9.1. Company Overview
10.9.2. Technology by Application Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Bio-Rad Laboratories
10.10.1. Company Overview
10.10.2. Technology by Application Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms